The Roskamp Institute, Sarasota, FL, USA.
Department of Life Sciences, The Open University, Milton Keynes, UK.
J Cereb Blood Flow Metab. 2021 Jun;41(6):1362-1378. doi: 10.1177/0271678X20954015. Epub 2020 Oct 13.
Incidences of repetitive mild TBI (r-mTBI), like those sustained by contact sports athletes and military personnel, are thought to be a risk factor for development of neurodegenerative disorders. Those suffering from chronic TBI-related illness demonstrate deficits in cerebrovascular reactivity (CVR), the ability of the cerebral vasculature to respond to a vasoactive stimulus. CVR is thus an important measure of traumatic cerebral vascular injury (TCVI), and a possible in vivo endophenotype of TBI-related neuropathogenesis. We combined laser speckle imaging of CVR in response to hypercapnic challenge with neurobehavioral assessment of learning and memory, to investigate if decreased cerebrovascular responsiveness underlies impaired cognitive function in our mouse model of chronic r-mTBI. We demonstrate a profile of blunted hypercapnia-evoked CVR in the cortices of r-mTBI mice like that of human TBI, alongside sustained memory and learning impairment, without biochemical or immunohistopathological signs of cerebral vessel laminar or endothelium constituent loss. Transient decreased expression of alpha smooth muscle actin and platelet-derived growth factor receptor β, indicative of TCVI, is obvious only at the time of the most pronounced CVR deficit. These findings implicate CVR as a valid preclinical measure of TCVI, perhaps useful for developing therapies targeting TCVI after recurrent mild head trauma.
重复性轻度创伤性脑损伤(r-mTBI)的发生率,如接触运动运动员和军人所遭受的那样,被认为是神经退行性疾病发展的一个风险因素。患有慢性创伤性脑损伤相关疾病的人表现出脑血管反应性(CVR)缺陷,即脑血管对血管活性刺激的反应能力。因此,CVR 是创伤性脑血管损伤(TCVI)的重要衡量标准,也是创伤性脑损伤相关神经发病机制的可能体内表型。我们结合激光散斑成像对高碳酸血症挑战的 CVR 反应与学习和记忆的神经行为评估,研究了慢性 r-mTBI 小鼠模型中认知功能障碍是否源于脑血管反应性降低。我们证明了 r-mTBI 小鼠皮质中的高碳酸血症诱发的 CVR 迟钝与人类 TBI 相似,同时伴有持续的记忆和学习障碍,而没有大脑血管层或内皮细胞成分丢失的生化或免疫组织病理学迹象。TCVI 标志物α平滑肌肌动蛋白和血小板衍生生长因子受体 β 的瞬时表达减少,仅在 CVR 缺陷最明显时明显。这些发现表明 CVR 是 TCVI 的有效临床前衡量标准,可能有助于在反复轻度头部创伤后开发针对 TCVI 的治疗方法。